1. BuchmanAL, ScolapioJ, FryerJ. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology2003;124:1111. CrossRef

2. JeppesenPB, MortensenPB. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut2000;46:701. CrossRef

3. O'KeefeSJ, BuchmanAL, FishbeinTM, et al.Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol2006;4:6. CrossRef

4. VanderhoofJA, YoungRJ, ThompsonJS. New and emerging therapies for short bowel syndrome in children. Paediatr Drugs2003;5:525. CrossRef

5. SiebertJR. Small‐intestine length in infants and children. Am J Dis Child1980;13:593.

6. NightingaleJM, BartramCI, Lennard‐JonesJE. Length of residual small bowel after partial resection: correlation between radiographic and surgical measurements. Gastrointest Radiol1991;16:305. CrossRef

7. YoshikawaT, TakeharaY, KikuyamaM, et al.Computed tomographic enteroclysis with air and virtual enteroscopy: protocol and feasibility for small bowel evaluation. Dig Liver Dis2012;4:297. CrossRef

8. MessingB, CrennP, BeauP, et al.Long‐term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology1999;117:1043. CrossRef

9. CrennP, Coudray‐LucasC, ThullierF, et al.Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology2000;119:1496. CrossRef

10. VanderhoofJA, LangnasAN. Short‐bowel syndrome in children and adults. Gastroenterology1997;113:1767. CrossRef

11. WalesPW, Christison‐LagayER. Short bowel syndrome: epidemiology and etiology. Semin Pediatr Surg2010;19:3. CrossRef

12. DabneyA, ThompsonJ, DiBaiseJ, et al.Short bowel syndrome after trauma. Am J Surg2004;188:792. CrossRef

13. ThompsonJS, DiBaiseJK, IyerKR, et al.Postoperative short bowel syndrome. J Am Coll Surg2005;201:85. CrossRef

14. ElrizK, Palascak‐JuifV, JolyF, et al.Crohn's disease patients with chronic intestinal failure receiving long‐term parenteral nutrition: a cross‐national adult study. Aliment Pharmacol Ther2011;34:931. CrossRef

15. van GossumA, BakkerH, BozettiF, et al.Home parenteral nutrition in adults: a European multicenter study in 1997. Clin Nutr1999;18:135. CrossRef

16. van GossumA, ColombB, HerbuterneX, et al.Home parenteral nutrition (HPN) in children: a multicentre survey in Europe in 1997. Clin Nutr1998;17:42. CrossRef

17. HowardL, AmentM, FlemingCR, et al.Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology1995;109:355. CrossRef

18. BorgstromB, DaalqA, LundhG, et al.Studies of intestinal digestion and absorption in the human. J Clin Invest1957;36:1521. CrossRef

19. FordtranJS, RectorFCJr, CarterNW. The mechanisms of sodium absorption in the human small intestine. J Clin Invest1968;47:884. CrossRef

20. NightingaleJM, KammMA, van der SijpJR, et al.Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the “colonic brake” to gastric emptying. Gut1996;39:267. CrossRef

21. FichA, SteadmanCJ, PhillipsSF, et al.Ileocolonic transit does not change after right hemicolectomy. Gastroenterology1992;103:794.

22. SingletonAO, RedmondDC, McMurrayJE. Ileocecal resection and small bowel transit and absorption. Ann Surg1964;159:690. CrossRef

23. DebongnieJC, PhillipsSF. Capacity of the colon to absorb fluid. Gastroenterology1978;74:698.

24. PironiL, StanghelliniV, MiglioliM, et al.Fat‐induced ileal brake in humans: a dose‐dependent phenomenon correlated to plasma levels of peptide YY. Gastroenterology1993;105:733.

25. JorgensenJR, FitchMD, MortensenPB, et al.In vivo absorption of medium‐chain fatty acids by the rat colon exceeds that of short‐chain fatty acids. Gastroenterology2001;120:1152. CrossRef

26. NordgaardI, HansenBS, MortensenPB. Importance of colonic support for energy absorption as small bowel failure proceeds. Am J Clin Nutr1996;64:222.

27. JeppesenPB, MortensenPB. Significance of a preserved colon for parenteral energy requirements in patients receiving home parenteral nutrition. Scand J Gastroenterol1998;33:1175. CrossRef

28. NightingaleJM, Lennard‐JonesJE, GertnerDJ, et al.Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut1992;33:1493. CrossRef

29. WilliamsNS, EvansP, KingRFGJ. Gastric acid secretion and gastrin production in the short bowel syndrome. Gut1985;26:914. CrossRef

30. CortotA, FlemingCR, MalageladaJR. Improved nutrient absorption after cimetidine in short‐bowel syndrome with gastric hypersecretion. N Engl J Med1979;300:79. CrossRef

31. MillerLJ, ClainJE, MalageladaJ‐R, et al.Control of human postprandial pancreatic exocrine secretion: a function of the gastroduodenal region. Dig Dis Sci1979;24:150. CrossRef

32. RemingtonM, FlemingCR, MalageladaJR. Inhibition of postprandial pancreatic and biliary secretion by loperamide in patients with short bowel syndrome. Gut1982;23:98. CrossRef

33. HoffmannAF, DanzingerRG. Physiologic and clinical significance of ileal resection. Surg Annu1972;4:305.

34. DowlingRH, BoothCC. Structural and functional changes following small intestinal resection in the rat. Clin Sci1967;32:139.

35. ThompsonJS, FergusonDC. Effect of the distal remnant on ileal adaptation. J Gastrointest Surg2000;4:430. CrossRef

36. HoffmannAF, PoleyJR. Role of bile acid malabsorption in the pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglycerides. Gastroenterology1972;62:918.

37. CarbonnelF, CosnesJ, ChevretS, et al.The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr1996;20:275. CrossRef

38. Quiros‐TejeiraRE, AmentME, TeyenL, et al.Long‐term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: 25‐year experience. J Pediatr2004;145:157. CrossRef

39. WilliamsonRCN, ChirM. Intestinal adaptation: structural, functional and cytokinetic changes. N Engl J Med1978;298:1393. CrossRef

40. CosnesJ, CarbonnelF, BeaugerieL, et al.Functional adaptation after extensive small bowel resection in humans. Eur J Gastroenterol Hepatol1994;6:197. CrossRef

41. DiBaiseJK, YoungRM, VanderhoofJA. Intestinal rehabilitation and the short bowel syndrome. Part 1. Am J Gastroenterol2004;99:1386. CrossRef

42. DiBaiseJK, YoungRM, VanderhoofJA. Intestinal rehabilitation and the short bowel syndrome. Part 2. Am J Gastroenterol2004;99:1823. CrossRef

43. JolyF, MayeurC, MessingB, et al.Morphological adaptation with preserved proliferation/trasnsporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol2009;297:G116. CrossRef

44. ThiesenA, DrozdowskiL, IordacheC, et al.Adaptation following intestinal resection: mechanisms and signals. Best Pract Res Clin Gastroenterol2003;17:981. CrossRef

45. LongshoreSW, WakemanD, McMellenM, et al.Bowel resection induced intestinal adaptation: progress from bench to bedside. Minerva Pediatr2009;61:239.

46. JolyF, MayeurC, BruneauA, et al.Drastic changes in fecal and mucosa‐associated microbiota in adult patients with short bowel syndrome. Biochimie2010;92:753. CrossRef

47. QuigleyEM, ThompsonJS. The motor response to intestinal resection: motor activity in the canine small intestine following distal resection. Gastroenterology1993;105:791.

48. TavakkolizadehA, WhangEE. Understanding and augmenting human intestinal adaptation: a call for more clinical research. JPEN J Parenter Enteral Nutr2002;26:151. CrossRef

49. NightingaleJM. Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol2003;17:907. CrossRef

50. HowardL, AshleyC. Management of complications in patients receiving home parenteral nutrition. Gastroenterology2003;124:1651. CrossRef

51. DiBaiseJK. Home parenteral nutrition: complications, survival, quality of life and costs. In: LangnasA, GouletO, QuigleyEMM, et al. (eds). Intestinal Failure: Diagnosis, Management and Transplantation. Massachusetts, USA: Blackwell Publishing; 2008: 130. CrossRef

52. DibbM, TeubnerA, TheisV, et al.Review article: the management of long‐term parenteral nutrition. Aliment Pharmacol Ther2013;37:587. CrossRef

53. DiBaiseJK, MatareseLE, MessingB, et al.Strategies for weaning parenteral nutrition in adult patients with short bowel syndrome. J Clin Gastroenterol2006;40(Suppl):S94. CrossRef

54. AnastCS, WinnackerJL, ForteLR, et al.Impaired release of parathyroid hormone in magnesium deficiency. Clin Endocrinol Metab1976;42:707. CrossRef

55. FukumotoS, MatsumotoT, TanakaY, et al.Renal magnesium wasting in a patient with short bowel syndrome with magnesium deficiency: effect of 1 alpha‐hydroxyvitamin D3 treatment. J Clin Endocrinol Metab1987;65:1201. CrossRef

56. BragaCB, VannucchiH, FreireCM, et al.Serum vitamins in adult patients with short bowel syndrome receiving intermittent parenteral nutrition. JPEN J Parenter Enteral Nutr2011;35:493. CrossRef

57. BoothCC. The effects of intestinal resection in man. Postgrad Med J1961;37:725. CrossRef

58. ArgenzioRA, LiacoxLA, AllisonMJ. Intestinal oxalate‐degrading bacteria reduce oxalate absorption and toxicity in guinea pigs. J Nutr1988;118:787.

59. HaderslevKV, JiellesenL, SorensenHA, et al.Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition. Am J Clin Nutr2002;76:482.

60. BeathS, PironiL, GabeS, et al.Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation2008;85:1378. CrossRef

61. KellyDA. Preventing parenteral nutrition liver disease. Early Hum Dev2010;86:683. CrossRef

62. CavicchiM, BeauP, CrennP, et al.Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med2000;132:525. CrossRef

63. PuderM, ValimC, MeiselJA, et al.Parenteral fish oil improves outcomes in patients with parenteral nutrition‐associated liver injury. Ann Surg2009;250:395.

64. MertesN, GrimmH, FurstP, et al.Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double‐blind, multicenter study. Ann Nutr Metab2006;50:253. CrossRef

65. DrayX, JolyF, ReijasseD, et al.Incidence, risk factors, and complications of cholelithiasis in patients with home parenteral nutrition. J Am Coll Surg2007;204:13. CrossRef

66. ThompsonJS. The role of prophylactic cholecystectomy in the short‐bowel syndrome. Arch Surg1996;131:556. CrossRef

67. DiBaiseJK, YoungRJ, VanderhoofJA. Enteric microbial flora, bacterial overgrowth and short bowel syndrome. Clin Gastroenterol Hepatol2006;4:11. CrossRef

68. GutierrezIM, KangKH, CalvertCE, et al.Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review. J Pediatr Surg2012;47:1150. CrossRef

69. ToskesPP, GiannellaRA, JervisHR, et al.Small intestinal mucosal injury in the experimental blind loop syndrome. Light‐ and electron‐microscopic and histochemical studies. Gastroenterology1975;68:193.

70. AttarA, FlourieB, RambaudJC, et al.Antibiotic efficacy in small intestinal bacterial overgrowth‐related chronic diarrhea: a crossover, randomized trial. Gastroenterology1999;117:794. CrossRef

71. VanderhoofJA, YoungRJ, MurrayN, et al.Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr1998;27:155. CrossRef

72. PetersenC. D‐lactic acidosis. Nutr Clin Pract2005;20:634. CrossRef

73. HoveH, MortensenPB. Colonic lactate metabolism and D‐lactic acidosis. Dig Dis Sci1995;40:320. CrossRef

74. VellaA, FarrugiaG. D‐lactic acidosis: pathologic consequence of saprophytism. Mayo Clin Proc1998;73:451. CrossRef

75. PullanJM. Massive intestinal resection. Proc R Soc Med1959;52:31.

76. ParrishCR. The clinician's guide to short bowel syndrome. Pract Gastroenterol2005;29:67.

77. MatareseLE. Nutrition and fluid optimization for patients with short bowel syndrome. JPEN J Parenter Enteral Nutr2013;37:161. CrossRef

78. SudanD, DiBaiseJ, TorresC, et al.A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg2005;9:165. CrossRef

79. NordgaardI, HansenBS, MortensenPB. Colon as a digestive organ in patients with short bowel. Lancet1994;343:373. CrossRef

80. McIntyrePB, FitchewM, Lennard‐JonesJE. Patients with a high jejunostomy do not need a special diet. Gastroenterology1986;91:25.

81. WoolfGM, MillerC, KurianR, et al.Nutritional absorption in short bowel syndrome. Evaluation of fluid, calorie, and divalent cation requirements. Dig Dis Sci1987;32:8. CrossRef

82. JeppesenPB, MortensenPB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut1998;43:478. CrossRef

83. CrennP, MorinMC, JolyF, et al.Net digestive absorption and adaptive hyperphagia in adult short bowel patients. Gut2004;53:1279. CrossRef

84. ByrneTA, VegliaL, CamelioM, et al.Beyond the prescription: optimizing the diet of patients with short bowel syndrome. Nutr Clin Pract2000;15:306. CrossRef

85. NightingaleJM, Lennard‐JonesJE, WalkerER, et al.Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution. Gut1992;33:759. CrossRef

86. MarteauP, MessingB, ArrigoniE, et al.Do short bowel patients need a lactose‐free diet?Nutrition1997;13:13. CrossRef

87. JeppesenPB, HowyCE, MortensenPB. Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr2000;54:632. CrossRef

88. LinR, MurtazinaR, ChaB, et al.D‐glucose acts via sodium/glucose cotransporter 1 to increase NHE3 in mouse jejunal brush border by a Na+/H+ exchange regulatory factor 2‐dependent process. Gastroenterology2011;140:560. CrossRef

89. KellyDG, NadeauJ. Oral rehydration solution: a “low‐tech” oft neglected therapy. Nutr Issues Gastroenterol2004;28:51.

90. SladenGE, DawsonAM. Inter‐relationships between the absorptions of glucose, sodium and water by the normal human jejunum. Clin Sci1969;36:119.

91. RodriguesCA, Lennard‐JonesJE, ThompsonDG, et al.What is the ideal sodium concentration of oral rehydration solutions for short bowel patients. Clin Sci1988;74:69. CrossRef

92. BuchmanAL, MoukarzelAA, BhutaS, et al.Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr1995;19:453. CrossRef

93. JolyF, DrayX, CorcosO, et al.Tube feeding improves intestinal absorption in short bowel syndrome patients. Gastroenterology2009;136:824. CrossRef

94. CawseySI, SooJ, GramlichLM. Home enteral nutrition: outcomes relative to indication. Nutr Clin Pract2010;25:296. CrossRef

95. LevyE, FrileuxP, SandrucciS, et al.Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome. Br J Surg1988;75:549. CrossRef

96. Noridian Healthcare Solutions. Physicians' Current Procedural Terminology (CPT), 4th edn, 2009. https://www.noridianmedicare.com/dme/coverage/docs/trees/tpn_policy_decision_tree.pdf%3fd. Accessed March 2013.

97. DiBaiseJK, ScolapioJS. Home parenteral and enteral nutrition. Gastroenterol Clin North Am2007;36:123. CrossRef

98. VanderhoofJA, YoungRJ. Enteral and parenteral nutrition in the care of patients with short bowel syndrome. Best Pract Res Clin Gastroenterol2003;17:997. CrossRef

99. ByrneTA, PersingerRL, YoungLS, et al.A new treatment for patients with short‐bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg1995;222:243. CrossRef

100. ByrneTA, CoxS, KarimbakasM, et al.Bowel rehabilitation: an alternative to long‐term parenteral nutrition and intestinal transplantation for some patients with short bowel syndrome. Transplant Proc2002;34:887. CrossRef

101. SeidnerDL, SchwartzLK, WinklerMF, et al.Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome‐associated intestinal failure. JPEN J Parenter Enteral Nutr2013;37:201. CrossRef

102. LadefofedK, ChristensenKC, HegnhojJ, et al.Effect of a long‐acting somatostatin analogue SMS 201‐995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut1989;30:943. CrossRef

103. NehraV, CamilleriM, BurtonD, et al.An open trial of octreotide long‐acting release in the management of short bowel syndrome. Am J Gastroenterol2001;96:1494. CrossRef

104. O'KeefeSJD, HaymondMW, BennetWM, et al.Long‐acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology1994;107:379.

105. SukhotnikI, KhateebK, KrauszMM, et al.Sandostatin impairs postresection intestinal adaptation in a rat model of short bowel syndrome. Dig Dis Sci2002;47:2095. CrossRef

106. KingRFGJ, NortonT, HillGL. A double‐blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust N Z J Surg1982;52:121. CrossRef

107. BuchmanAL, FryerJ, WallinA, et al.Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. JPEN J Parenter Enteral Nutr2006;30:487. CrossRef

108. LittleKH, SchillerLR, BilhartzLE, et al.Treatment of severe steatorrhea with ox bile in an ileectomy patient with residual colon. Dig Dis Sci1992;37:929. CrossRef

109. HeydornS, JeppesenPB, MortensenPB. Bile acid replacement therapy with cholylsarcosine for short‐bowel syndrome. Scand J Gastroenterol1999;34:818. CrossRef

110. IslamRS, DiBaiseJK. Bile acids: an underrecognized and underappreciated cause of chronic diarrhea. Pract Gastroenterol2012;36:32.

111. KotlerDP, LevineGM. Reversible gastric and pancreatic hyposecretion after long‐term total parenteral nutrition. N Engl J Med1979;300:241. CrossRef

112. Tolga MuftuogluMA, CivakT, CetinS, et al.Effects of probiotics on experimental short‐bowel syndrome. Am J Surg2011;202:461. CrossRef

113. UchidaK, TakahashiT, InoueM, et al.Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int2007;23:243. CrossRef

114. WilmoreDW, LaceyJM, SoultanakisRP, et al.Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg1997;226:288. CrossRef

115. ZhuW, LiN, RenJ, et al.Rehabilitation therapy for short bowel syndrome. Chin Med J2002;115:776.

116. ByrneTA, WilmoreDW, IyerK, et al.Growth hormone, glutamine and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome. A prospective, randomized, placebo‐controlled, double‐blind clinical trial. Ann Surg2005;242:665. CrossRef

117. TangprichaV, LuoM, Fernandez‐EstivarizC, et al.Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation. JPEN J Parenter Enteral Nutr2006;30:480. CrossRef

118. ScolapioJS, CamilleriM, FlemingCR, et al.Effect of growth hormone, glutamine, and diet on adaptation in short bowel syndrome: a randomized, controlled study. Gastroenterology1997;113:1074. CrossRef

119. SzkudlarekJ, JeppesenPB, MortensenPB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double‐blind, crossover, placebo‐controlled study. Gut2000;47:199. CrossRef

120. SeguyD, VahediK, KapelN, et al.Low‐dose growth hormone in adult home parenteral nutrition‐dependent short bowel syndrome patients: a positive study. Gastroenterology2003;124:293. CrossRef

121. WalesPW, NasrA, de SilvaN, et al.Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev2010;(6):CD006321.

122. GiovanucciE, PollakM. Risk of cancer after growth‐hormone treatment. Lancet2002;360:268. CrossRef

123. DruckerDJ, ErlichP, AsaSL, et al.Induction of intestinal epithelial proliferation by glucagon‐like peptide 2. Proc Natl Acad Sci U S A1996;93:7911. CrossRef

124. GhateiMA, GoodladRA, TaheriS, et al.Proglucagon‐derived peptides in intestinal epithelial proliferation. Glucagon‐like peptide‐2 is a major mediator of intestinal epithelial proliferation in rats. Dig Dis Sci2001;46:1255. CrossRef

125. ScottRB, KirkD, MacNaughtonWK, et al.GLP‐2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol1998;275:G911.

126. WojdemannM, WettergrenA, HartmannB, et al.Glucagon‐like peptide‐2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol1998;33:828. CrossRef

127. WojdemannM, WettergrenA, HartmannB, et al.Inhibition of sham feeding‐stimulated human gastric acid secretion by glucagon‐like peptide‐2. J Clin Endocrinol Metab1999;84:2513. CrossRef

128. JeppesenPB, HartmannB, ThulesenJ, et al.Glucagon‐like peptide 2 improves nutrient absorption and nutritional status in short‐bowel patients with no colon. Gastroenterology2001;120:806. CrossRef

129. JeppesenPB, SanguinettiEL, BuchmanA, et al.Teduglutide (ALX‐0600), a dipeptidyl peptidase IV resistant glucagon‐like peptide analogue, improves intestinal function in short bowel syndrome patients. Gut2005;54:1224. CrossRef

130. JeppesenPB, GilroyR, PertkiewiczM, et al.Randomised placebo‐controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut2011;60:902. CrossRef

131. TappendenKA, EdelmanJ, JoelssonB. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome. J Clin Gastroenterol2013;47:602. CrossRef

132. JeppesenPB, PertkiewiczM, MessingB, et al.Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology2012;143:1473. CrossRef

133. JeppesenPB, O'KeefeS, ChuH, et al.Short bowel syndrome patients with intestinal failure (SBS‐IF) successfully achieved complete independence from parenteral nutrition and/or intravenous fluid (PN/IV) with teduglutide. Gastroenterology2012;142:S369. CrossRef

134. KunkelD, BasseriB, LowK, et al.Efficacy of the glucagon‐like peptide‐1 agonist exenatide in the treatment of short bowel syndrome. Neurogastroenterol Motil2011;23:739. CrossRef

135. MadsenKB, Askov‐HansenC, NaimiRM, et al.Acute effects of continuous infusions of glucagon‐like peptide (GLP)‐1, GLP‐2 and the combination (GLP‐1+GLP‐2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo‐controlled study. Regul Pept2013;184:30. CrossRef

136. van der HulstRR, van KreelBK, von MeyenfeldtMF, et al.Glutamine and the preservation of gut integrity. Lancet1993;341:1363. CrossRef

137. BeaugererieL, CarbonnelF, HecketsweilerB, et al.Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with a short bowel. Aliment Pharmacol Ther1997;11:741. CrossRef

138. ScolapioJS, McGreevyK, TennysonGS, et al.Effect of glutamine in short‐bowel syndrome. Clin Nutr2001;20:319. CrossRef

139. ZhouX, LiYX, LiN, et al.Glutamine enhances the gut trophic effect of growth hormone in rat after massive small bowel resection. J Surg Res2001;99:47. CrossRef

140. BioloG, IscraF, BosuttiA, et al.Growth hormone decreases muscle glutamine production and stimulates protein syntheses in hypercatabolic patients. Am J Physiol2000;279:E323.

141. ShamJ, MartinG, MeddingJB, et al.Epidermal growth factor improves nutritional outcome in a rat model of short bowel syndrome. J Pediatr Surg2002;37:765. CrossRef

142. SigaletDL, MartinGR, ButznerJD, et al.A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg2005;40:763. CrossRef

143. AndrewsNJ, IrvingMH. Human gut hormone profiles in patients with short‐bowel syndrome. Dig Dis Sci1992;37:729. CrossRef

144. ThompsonJS. Reoperation in patients with the short bowel syndrome. Am J Surg1992;164:453. CrossRef

145. ThompsonJS. Surgical rehabilitation of intestine in short bowel syndrome. Surgery2004;135:465. CrossRef

146. NguyenBT, BlatchfordGJ, ThompsonJS, et al.Should intestinal continuity be restored after massive intestinal resection?Am J Surg1989;158:577. CrossRef

147. RegeAS, SudanDL. Autologous gastrointestinal reconstruction: review of the optimal nontransplant surgical options for adults and children with short bowel syndrome. Nutr Clin Pract2013;28:65. CrossRef

148. ThompsonJS, RikkersLF. Surgical alternatives for the short bowel syndrome. Am J Gastroenterol1990;35:137.

149. LayecS, BeyerL, CorcosO, et al.Increased intestinal absorption by segmental reversal of the small bowel in adult patients with short‐bowel syndrome: a case‐control study. Am J Clin Nutr2013;97:100. CrossRef

150. BianchiA. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med1997;90:429.

151. KimHB, FauzaD, GarzaJ, et al.Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg2003;38:425. CrossRef

152. ChingYA, FitzgibbonsS, ValimC, et al.Long‐term nutritional and clinical outcomes after serial transverse enteroplasty at a single institution. J Pediatr Surg2009;44:939. CrossRef

153. AmiotA, MessingB, CorcosO, et al.Determinants of home parenteral nutrition dependency and survival of 268 patients with non‐malignant short bowel syndrome. Clin Nutr2013;32:368. CrossRef

154. ThompsonJS. Comparison of massive vs. repeated resection leading to short bowel syndrome. J Gastrointest Surg2000;4:101. CrossRef

155. ThompsonJS, LangnasAN, PinchLW, et al.Surgical approach to short‐bowel syndrome. Experience in a population of 160 patients. Ann Surg1995;222:600. CrossRef

156. ScolapioJS, FlemingCR, KellyDG, et al.Survival of home parenteral nutrition‐treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc1999;74:217. CrossRef

157. MessingB, LemannM, LandaisP, et al.Prognosis of patients with nonmalignant chronic intestinal failure receiving long‐term home parenteral nutrition. Gastroenterology1995;108:1005. CrossRef

158. CarlssonE, BoseausI, NordgrenS. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr2003;22:445. CrossRef

159. JeppesenPB, LangholzE, MortensenPB. Quality of life in patients receiving home parenteral nutrition. Gut1999;44:844. CrossRef

160. BaxterJP, FayersPM, McKinlayAW. A review of the quality of life of adult patients treated with long‐term parenteral nutrition. Clin Nutr2006;25:543. CrossRef

161. DetskyAS, McLaughlinJR, AbramsHB, et al.Quality of life of patients on long‐term total parenteral nutrition at home. J Gen Intern Med1986;1:26. CrossRef

162. SmithCE. Quality of life in long term TPN patients and their family caregivers. JPEN J Parenter Enteral Nutr1993;17:501. CrossRef

163. SmithCE, CurtasS, WerkonitchM, et al.Home parenteral nutrition: does affiliation with a national support and education organization improve patient outcome?JPEN J Parenter Enteral Nutr2002;26:159. CrossRef

164. BerghöferP, FragkosKC, BaxterJP, et al.Development and validation of the disease‐specific Short Bowel Syndrome‐Quality of Life (SBS‐QoL™) scale. Clin Nutr2013;32:789. CrossRef

165. GilroyR, SudanD. Liver and small bowel transplantation: therapeutic alternatives for the treatment of liver disease and intestinal failure. Semin Liver Dis2000;20:437. CrossRef

166. StarzlTE, KauppHAJr, BrockDR, et al.Homotransplantation of multiple visceral organs. Am J Surg1962;103:219. CrossRef

167. LilleheiRC, IdezukiY, FeemsterJA, et al.Transplantation of stomach, intestine and pancreas: experimental and clinical observations. Surgery1967;62:721.

168. OkumuraM, FujimuraI, FerrariAA, et al.Transplantation of the small intestine. Case report. Rev Hosp Clin Fac Med Sao Paulo1969;24:39.

169. OlivierC, RettoriR, BaurO, et al.A case of orthotopic transplantation of the jejuno‐ileum and the ascending and transverse colon. Presse Med1969;77:1275.

170. AlicanF, HardyJD, CayirliM, et al.Intestinal transplantation: laboratory experience and report of a clinical case. Am J Surg1971;121:150. CrossRef

171. GrantD, WallW, MimeaultR, et al.Successful small bowel‐liver transplantation. Lancet1990;335:181. CrossRef

172. StarzlT, TodoS, TzakisA, et al.The many faces of multivisceral transplantation. Surg Gynecol Obstet1991;172:335.

173. FishbeinTM, KaufmanSS, FlormanSS, et al.Isolated intestinal transplantation: proof of clinical efficacy. Transplantation2003;76:636. CrossRef

174. Di BenedettoF, LauroA, MasettiM, et al.Outcomes after adult isolated small bowel transplantation: experience from a single European centre. Dig Liver Dis2005;37:240. CrossRef

175. GrantD, Abu‐ElmagdK, ReyesJ, et al.; Intestine Transplant Registry. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg2005;241:607. CrossRef

176. HowardL, HeapheyL, FlemingCR, et al.Four years of North American registry home parenteral nutrition outcome data and their implications for patient management. JPEN J Parenter Enteral Nutr1991;15:384. CrossRef

177. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 annual data report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation. Am J Transplant2012;12(Suppl 1):1.

178. KaufmanS, AtkinsonJ, BianchiA, et al.Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant2001;5:80. CrossRef

179. PironiL, ForbesA, JolyF, et al.Survival of patients identified as candidates for intestinal transplantation: a 3‐ year prospective follow‐up. Gastroenterology2008;135:61. CrossRef

180. MangusRS, TectorAJ, KubalCA, et al.Multivisceral transplantation: expanding indications and improving outcomes. J Gastrointest Surg2013;17:179. CrossRef

181. MatsumotoC, FishbeinT. Modified multivisceral transplantation with splenopancreatic preservation. Transplantation2007;83:234. CrossRef

182. SudanD, IyerK, DeRooverA, et al.A new technique for combined liver/intestinal transplantation. Transplantation2001;72:1846. CrossRef

183. Abu‐ElmagdK. The small bowel contained allografts: existing and proposed nomenclature. Am J Transplant2011;11:184. CrossRef

184. MazariegosG, StefficD, HorslenS, et al.Intestine transplantation in the United States 1999‐2008. Am J Transplant2010;10:1029. CrossRef

185. GerlachUA, PascherA. Technical advances for abdominal wall closure after intestinal and multivisceral transplantation. Curr Opin Organ Transplant2012;17:258. CrossRef

186. FryerJ, PellarS, OrmondD, et al.Mortality in candidates waiting for combined liver‐intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl2003;9:148. CrossRef

187. ChungfatN, DixlerI, CohranV, et al.Impact of parenteral nutrition‐associated liver disease on intestinal transplant waitlist dynamics. J Am Coll Surg2007;205:755. CrossRef

188. CaiJ. Intestine and multivisceral transplantation in the United States: a report of 20‐year national registry data (1990‐2009). Clin Transpl2009;83.

189. TzvetanovIG, OberholzerJ, BenedettiE. Current status of living donor small bowel transplantation. Curr Opin Organ Transplant2010;15:346. CrossRef

190. SudanD. Long‐term outcomes and quality of life after intestine transplantation. Curr Opin Organ Transplant2010;15:357. CrossRef

191. IyerK, HorslenS, IversonA, et al.Nutritional outcome and growth of children after intestinal transplantation. J Pediatr Surg2002;37:464. CrossRef

192. SudanD, HorslenS, BothaJ, et al.Quality of life after pediatric intestinal transplantation: the perception of pediatric recipients and their parents. Am J Transplant2004;4:407. CrossRef

193. RoveraGM, DiMartiniA, SchoenRE, et al.Quality of life of patients after intestinal transplantation. Transplantation1998;66:1141. CrossRef

194. PironiL, BaxterFP, LauroA, et al.Assessment of quality of life on home parenteral nutrition and after intestinal transplantation using treatment‐specific questionnaires. Am J Transplant2012;12:560. CrossRef

195. FlorescuD, QuiF, LangnasA, et al.Bloodstream infections during the first year after small bowel transplantation. Pediatr Infect Dis J2012;31:700. CrossRef

196. ZiringD, TranR, EdelsteinS, et al.Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplant Proc2004;36:379. CrossRef

197. SudanDL, ChinnakotlaS, HorslenS, et al.Basiliximab decreases the incidence of acute rejection after intestinal transplantation. Transplant Proc2002;34:940. CrossRef

198. GupteGL, BeathSV. Update on intestinal rehabilitation after intestinal transplantation. Curr Opin Organ Transplant2009;14:267. CrossRef

199. Abu‐ElmagdKM, ReyesJ, FungJJ, et al.Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc1999;31:582. CrossRef

200. SudanD. Cost and quality of life after intestinal transplantation. Gastroenterology2006;130:S158. CrossRef